Abstract
Objective. The aim of the study was to identify possible paradoxal embolism (PE) using contrast transthoracic echocardiography (TTE) with a functional test to identify the patent foramen ovale (PFO) associated strokes in children for further endovascular prevention of cryptogenic arterial ishemic stroke (CAIS) and transient ishemic attack (TIA).
Material and methods. In the period from January 2019 to December 2023, 31 children diagnosed with CAIS and TIA were searched for a right-to-left shunt (RLS) using TTE with a bubble test with a mandatory component of the study – performing a test – Valsalva maneuver. The assessment of the probability of PE and the assessment of the clinical significance of PFO was carried out in accordance with the PASCAL classification and the Risk of Paradoxical Embolism Score (RoPE) scale.
Results. TTE revealed PFO in 15 (48.4%) out of 31 children with a diameter of Мe (Q1 –Q3 ) 2.5 (2.5–4.0) mm. Atrial septal aneurysm (ASA) was detected in 4 children, ASA was combined with PFO in 3 children. In cTTE, a RLS was found in 18 patients: in 15 of them, TTE confirmed the presence of PFO, while in 3 PFO it was not identified. A small shunt was detected in 4 (22.2%) patients, a medium shunt in 3 (11.1%) and a large shunt in 11 (66.7%). In 13 patients, shunting through the interatrial septum was not detected. All 31 patients were at high risk of developing PE according to RoPEs scale – 9 or more points. In accordance with the PASCAL classification, in 68.4% of patients, PFO can be considered as a probable cause of СAIS, in 31.6% of patients, the role of PFO in the development of stroke was possible. In 10 (38.4%) patients with CIS and in 2 (40%) children with TIA with large RLS and a probable cause of PFO-associated stroke according to the PASCAL classification, an intercollegiate decision was made to perform transcatheter closure of the PFO. In 100% of cases, hermetic closure of the PFO was determined by the absence of blood discharges on the interatrial septum.
Conclusions. All children who have undergone cryptogenic stroke and/or TIA of unknown etiology require cTTE to determine possible PE through PFO with further optimization of secondary prevention of CIS and TIA. Endovascular closure of PFO is an effective and safe method of secondary prevention of embolic cryptogenic strokes in children.
References
- Ohuma E., Moller A.-B., Bradley E., Chakwera S., Hussain-Alkhateeb L., Lewin A. et al. National, regional, and worldwide estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet. 2023; 402 (10409): 1261–71. DOI: 10.1016/S0140-6736(23)00878-4
- Numis A., Fox C. Arterial ischemic stroke in children: risk factors and etiologies. Curr. Neurol. Neurosci. Rep. 2014; 14 (1): 422. DOI: 10.1007/s11910-013-0422-8
- Tsze D., Valente J. Pediatric stroke: a review. Emerg. Med. Int. 2011; 2011: 734506. DOI: 10.1155/2011/734506
- Bernard T., Goldenberg N. Pediatric arterial ischemic stroke. Hematol. Oncol. Clin. North Am. 2010; 24 (1): 167–80. DOI: 10.1016/j.hoc.2009.11.007
- Agnetti A., Carano N., Sani E., Tchana B., Allegri V., Bernasconi S. et al. Cryptogenic stroke in children: possible role of patent foramen ovale. Neuropediatrics. 2006; 37 (1): 53–6. DOI: 10.1055/s-2006-923936
- Chung B., Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics. 2004; 114 (2): e206–12. DOI: 10.1542/peds.114.2.e206
- deVeber G., Kirton A., Booth F.A., Yager J.Y., Wirrell E.C., Wood E. et al. Epidemiology and outcomes of arterial ischemic stroke in children: the Canadian Pediatric Ischemic Stroke Registry. Pediatr. Neurol. 2017; 69: 58–70. DOI: 10.1016/j.pediatrneurol.2017.01.016
- Петрухин А.С., Бобылова М.Ю., Михайлова С.В. Этиология инсульта у детей. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2015; 15 (32): 64–74. DOI: 10.17116/jnevro20151153264-74 Petrukhin A.S., Bobylova M.Iu., Mikhaĭlova S.V. Etiology of stroke in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2015; 115 (3–2): 64–74 (in Russ.). DOI: 10.17116/jnevro20151153264-74
- Khan R., Chan A.K., Mondal T.K., Paes B.A. Thrombosis and Hemostasis in Newborns (THIN) Group. Patent foramen ovale and stroke in childhood: a systematic review of the literature. Eur. J. Paediatr. Neurol. 2016; 20 (4): 500–11. DOI: 10.1016/j.ejpn.2016.04.012
- Zykov V.P., Vasiliev S.A., Komarova I.B., Chuchin M.Yu., Ushakova L.V., Shvabrina T.V. et al. Ischemic stroke in childhood. Medical Business. 2009; 2: 12–20.
- Melkumova E., Thaler D.E. Cryptogenic stroke and patent foramen ovale risk assessment. Interv. Cardiol. Clin. 2017; 6 (4): 487–93. DOI: 10.1016/j.iccl.2017.05.005
- Abdelghani M., El-Shedoudy S.A.O., Nassif M., Bouma B.J., de Winter R.J. Management of patients with patent foramen ovale and cryptogenic stroke: an update. Cardiology. 2019; 143 (1): 62–72. DOI: 10.1159/000501028
- Mackey J. Evaluation and management of stroke in young adults. Continuum (Minneap. Minn.). 2014; 20 (2): 352–69. DOI: 10.1212/01.CON.0000446106.74796.e9
- Sinclair A.J., Fox C.K., Ichord R.N., Almond C.S., Bernard T.J., Beslow L.A. et al. Stroke in children with cardiac disease: report from the International Pediatric Stroke Study Group Symposium. Pediatr. Neurol. 2015; 52 (1): 5–15. DOI: 10.1016/j.pediatrneurol.2014.09.016
- Shih E.K., Beslow L.A., Natarajan S.S., Falkensammer C.B., Messé S.R., Ichord R.N. Prevalence of patent foramen ovale in a cohort of children with cryptogenic ischemic stroke. Neurology. 2021; 97 (21): e2096–e2102. DOI: 10.1212/WNL.0000000000012892
- Windecker S., Stortecky S., Meier B. Paradoxical embolism. J. Am. Coll. Cardiol. 2014; 64 (4): 403–15. DOI: 10.1016/j.jacc.2014.04.063
- Cohnheim J. Thrombosis and embolism. In: Lectures on general pathology: a handbook for physicians and students. Berlin: August Hirschwald; 1877: 134.
- Sun Y.P., Homma S. Patent foramen ovale and stroke. Circ. J. 2016; 80 (8): 1665–73. DOI: 10.1253/circj.CJ-16-0534
- Bang O.Y., Lee M.J., Ryoo S., Kim S.J., Kim J.W. Patent foramen ovale and stroke-current status. J. Stroke. 2015; 17 (3): 229–37. DOI: 10.5853/jos.2015.17.3.229
- Schneider B., Zienkiewicz T., Jansen V., Hofmann T., Noltenius H., Meinertz T. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am. J. Cardiol. 1996; 77 (14): 1202–9. DOI: 10.1016/s0002-9149(96)00163-4
- Marriott K., Manins V., Forshaw A., Wright J., Pascoe R. Detection of right-to-left atrial communication using agitated saline contrast imaging: experience with 1162 patients and recommendations for echocardiography. J. Am. Soc. Echocardiogr. 2013; 26 (1): 96–102. DOI: 10.1016/j.echo.2012.09.007
- Elgendy A.Y., Saver J.L., Amin Z., Boudoulas K.D., Carroll J.D., Elgendy I.Y. et al. Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurol. 2020; 77 (7): 878–86. DOI: 10.1001/jamaneurol.2020.0458
- Hubail Z., Lemler M., Ramaciotti C., Moore J., Ikemba C. Diagnosing a patent foramen ovale in children: is transesophageal echocardiography necessary? Stroke. 2011; 42 (1): 98–101. DOI: 10.1161/STROKEAHA.110.595876
- Nam K.W., Guk H.S., Kwon H.M., Lee Y.S. Diffusionweighted imaging patterns according to the right-to-left shunt amount in cryptogenic stroke. Cerebrovasc. Dis. 2019; 48 (1–2): 45–52. DOI: 10.1159/000502882
- Horner S., Ni X.S., Weihs W., Harb S., Augustin M., Duft M. et al. Simultaneous bilateral contrast transcranial doppler monitoring in patients with intracardiac and intrapulmonary shunts. J. Neurol. Sci. 1997; 1; 150 (1): 49–57. DOI: 10.1016/s0022-510x(97)05367-7
- Droste D.W., Kriete J.U., Stypmann J., Castrucci M., Wichter T., Tietje R. et al. Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: comparison of different procedures and different contrast agents. Stroke. 1999; 30 (9): 1827–32. DOI: 10.1161/01.str.30.9.1827
- Chechetkin A.O., Karshieva A.R., Kravchenko M.A., Belopasova A.V., Kalashnikova L.A., Dobrynina L.A. Pulmonary arteriovenous shunt as a cause of paradoxical cerebral embolism: possibilities of ultrasound diagnosis. Russian Military Medical Academy Reports. 2019; S3: 162– 4. DOI: 10.32863/1682-7392-2019-3-67-162-164
- Mehryakov S.A., Kulesh A.A., Pokalenko E.A., Syromyatnikova L.I., Kulikova S.P., Drobakha V.E. et al. The phenomenon of paradoxical embolism in patients with embolic cryptogenic stroke. Neurology, neuropsychiatry, psychosomatics. 2020; 12 (1): 13–21. DOI: 10.14412/2074- 2711-2020-1-13-21
- Kent D.M., Saver J.L., Kasner S.E., Nelson J., Carroll J.D., Chatellier G. et al. Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke. JAMA. 2021; 14; 326 (22): 2277–86. DOI: 10.1001/jama.2021.20956
- Nakayama R., Takaya Y., Akagi T., Watanabe N., Ikeda M., Nakagawa K. et al. Identification of high-risk patent foramen ovale associated with cryptogenic stroke: development of a scoring system. J. Am. Soc. Echocardiogr. 2019; 32 (7): 811–6. DOI: 10.1016/j.echo.2019.03.021
- Schuchlenz H.W., Saurer G., Weihs W., Rehak P. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J. Am. Soc. Echocardiogr. 2004; 17 (3): 231–3. DOI: 10.1016/j.echo.2003.12.003
- Stortecky S., da Costa B.R., Mattle H.P., Carroll J., Hornung M., Sievert H. et al. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur. Heart J. 2015; 36 (2): 120–8. DOI: 10.1093/eurheartj/ehu292
- Sel K., Aykan H.H., Duman D., Aypar E., Özkutlu S., Alehan D. et al. Transcatheter closure of the patent foramen ovale in children: intermediate-term follow-up results. Cardiol. Young. 2017; 27 (8): 1545–9. DOI: 10.1017/S1047951117000725
- Kleindorfer D.O., Towfighi A., Chaturvedi S., Cockroft K.M., Gutierrez J., Lombardi-Hill D. et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021; 52 (7): e364–e467. DOI: 10.1161/STR.0000000000000375
- Kavinsky C.J., Szerlip M., Goldsweig A.M., Amin Z., Boudoulas K.D., Carroll J.D. et al. SCAI Guidelines for the management of patent foramen ovale. Journal of the Society for Cardiovascular Angiography & Interventions. 2022; 100039. DOI: 10.1016/j.jscai.2022.100039
- Kasner S.E., Lattanzi S., Fonseca A.C., Elgendy A.Y. Uncertainties and controversies in the management of ischemic stroke and transient ischemic attack patients with patent foramen ovale. Stroke. 2021; 52 (12): e806–e819. DOI: 10.1161/STROKEAHA.121.034778
- Roach E.S., Golomb M.R., Adams R., Biller J., Daniels S., Deveber G. et al. American Heart Association Stroke Council; Council on Cardiovascular Disease in the Young. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008; 39 (9): 2644–91. DOI: 10.1161/STROKEAHA.108.189696
- Miton N., Godart F., Milani G., Jalal Z., Karsenty C., Baruteau A.E. et al. Patent foramen ovale closure in children without cardiopathy: Child-PFO study. Arch. Cardiovasc. Dis. 2020; 113 (8–9): 513–24. DOI: 10.1016/j.acvd.2020.03.021
- Saharan S., Vettukattil J., Bhat A., Amula V., Bansal M., Chowdhury D. et al. Patent foramen ovale in children: unique pediatric challenges and lessons learned from adult literature. Ann. Pediatr. Cardiol. 2022; 15 (1): 44–52. DOI: 10.4103/apc.apc_67_21
- Hartman A.L., Lunney K.M., Serena J.E. Pediatric stroke: do clinical factors predict delays in presentation? J. Pediatr. 2009; 154 (5): 727–32. DOI: 10.1016/j.jpeds.2008.11.011
- Mallick A.A., Ganesan V., Kirkham F.J., Fallon P., Hedderly T., McShane T. et al. Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study. Lancet Neurol. 2014; 13 (1): 35–43. DOI: 10.1016/S1474-4422(13)70290-4
- Tuckuviene R., Christensen A.L., Helgestad J., Johnsen SP., Kristensen S.R. Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis in Denmark 1994–2006: a nationwide population-based study. Acta Paediatr. 2011; 100: 543–9. DOI: 10.1111/j.1651-2227.2010.02100
- Kent D.M., Ruthazer R., Weimar C., Mas J.L., Serena J., Homma S. et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013; 81 (7): 619–25. DOI: 10.1212/WNL.0b013e3182a08d59
- Lee P.H., Song J.K., Kim J.S., Heo R., Lee S., Kim D.H. et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO Trial. J. Am. Coll. Cardiol. 2018; 71 (20): 2335–42. DOI: 10.1016/j.jacc.2018.02.046
About the authors
- Mariya M. Kurako, Cand. Med. Sci., Functional Diagnostics Doctor, Ultrasonic Diagnostician; ORCID
- Manolis G. Pursanov, Dr. Med. Sci., Endovascular Surgeon; ORCID
- Mikhail A. Abramyan, Dr. Med. Sci., Professor of Chair of Pediatrics, Head of Department of Emergency Cardiac Surgery and Interventional Cardiology; ORCID
- Aleksey V. Bedin, Cardiovascular Surgeon; ORCID
- Inna O. Shchederkina, Cand. Med. Sci., Head of Center for the Treatment of Cerebrovascular Pathology in Children and Adolescents (Children’s Stroke Center), Neurologist, Epileptologist; ORCID